COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 2431: Articles 24301-24310  | Next

CETSA MS profiling for a comparative assessment of FDA approved antivirals repurposed for COVID-19 therapy identifies Trip13 as a Remdesivir off-target
Friman, T., Chernobrovkin, A., Martinez Molina, D., Arnold, L. H.
10.1101/2020.07.19.210492 — Posted: 2020-07-20
Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication
Silvas, J. A., Jureka, A. S., Nicolini, A. M., Chvatal, S. A., Basler, C. F.
10.1101/2020.07.18.210211 — Posted: 2020-07-20
Haplotype Explorer: an infection cluster visualization tool for spatiotemporal dissection of the COVID-19 pandemic
Kawano-Sugaya, T., Yatsu, K., Sekizuka, T., Itokawa, K., Hashino, M., Tanaka, R., Kuroda, M.
10.1101/2020.07.19.179101 — Posted: 2020-07-20
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models
Stegmann, K. M., Dickmanns, A., Gerber, S., Nikolova, V., Klemke, L., Manzini, V., Schloesser, D., Bierwirth, C., Freund, J., Sitte, M., Lugert, R., Salinas, G., Goerlich, D., Wollnik, B., Gross, U., Dobbelstein, M.
10.1101/2020.07.18.210013 — Posted: 2020-07-20
Cryo-electron Microscopy and Exploratory Antisense Targeting of the 28-kDa Frameshift Stimulation Element from the SARS-CoV-2 RNA Genome
Zhang, K., Zheludev, I. N., Hagey, R. J., Wu, M. T.-P., Haslecker, R., Hou, Y. J., Kretsch, R., Pintilie, G. D., Rangan, R., Kladwang, W., Li, S., Pham, E. A., Bernardin, C., Baric, R. S., Sheahan, T. P., Dsouza, V., Glenn, J. S., Chiu, W., Das, R.
10.1101/2020.07.18.209270 — Posted: 2020-07-20
A New Adaptive Logistic Model for Epidemics and the Resurgence of COVID-19 in the United States
Roberts, D. H.
10.1101/2020.07.17.20156109 — Posted: 2020-07-20
Inverted covariate effects for mutated 2nd vs 1st waveCovid-19: high temperature spread biased for young
Seligmann, H., Iggui, S., Rachdi, M., Vuillerme, N., Demongeot, J.
10.1101/2020.07.12.20151878 — Posted: 2020-07-20
High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients
Song, X., Hu, W., Yu, H., Zhao, L., Zhao, Y., Zhao, Y.
10.1101/2020.07.18.210120 — Posted: 2020-07-20
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy
Alteri, C., Cento, V., Piralla, A., Costabile, V., Tallarita, M., Colagrossi, L., Renica, S., Giardina, F., Novazzi, F., Gaiarsa, S., Matarazzo, E., Antonello, M., Vismara, C., Fumagalli, R., Epis, O. M., Puoti, M., Perno, C. F., Baldanti, F.
10.1101/2020.07.19.20152322 — Posted: 2020-07-20
The Infectious Nature of Patient-Generated SARS-CoV-2 Aerosol
Santarpia, J. L., Herrera, V. L., Rivera, D. N., Ratnesar-Shumate, S., Reid, S. P., Denton, P. W., Martens, J. W. S., Fang, Y., Conoan, N., Callahan, M. V., Lawler, J. V., Brett-Major, D. M., Lowe, J. J.
10.1101/2020.07.13.20041632 — Posted: 2020-07-20 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).